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Abstract 
Laminin isolated from human placenta was subjected to prolonged pepsin digestion. Seven peptide fragments (designated N1 to N7) 
were separated by ion-exchange chromatography and gel filtration and characterised by SDS-polyacrylamide g l electrophoresis and 
immunoblotting. The molecular size of the laminin fragments varied from approx. 900000 (N1) to 28 000 (N7). Epithelial cells obtained 
from normal kidneys and patients with autosomal dominant polycystic kidney disease (ADPKD) were cultured. The incorporation of 
[3H]thymidine was measured over 96 h to determine the effect of the addition of the different fragments and whole laminin from EHS 
tumour to the cells. The rate of growth of both normal and polycystic ells was increased in the presence of the laminin fragments but this 
effect was more pronounced in the ADPKD cells. 
1. Introduction 
Autosomal dominant polycystic kidney disease (AD- 
PKD) is the most common genetic disorder leading to 
end-stage renal failure. The incidence of the disease is 1 in 
800 of live births in caucasians and it accounts for about 
12% of patients on renal dialysis. The age of onset is 
between 20 and 40 years and the mean age of death is 50 
years [1]. Cysts are derived from occlusion of the proximal 
tubules followed by dilation which may be accompanied 
by a loss of function [2]. Although renal cysts are lined by 
polarised epithelial cells, these may be defective since it 
has been established that sodium-potassium-ATPase ctiv- 
ity is increased and its distribution along the tubules 
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changed [3,4]. Many of these changes may be as a result of 
dedifferentiation [5]. The gene responsible for most cases 
of ADPKD has recently been localised by The European 
Polycystic Kidney Disease Consortium [6] and encodes a 
14 kb transcript. 
A number of hypotheses have been put forward to 
explain the formation of renal cysts, including an increase 
in epidermal growth factor (EGF) synthesis [7], and a 
decreased sensitivity to transforming rowth factor /3 
(TGF-/3; [8]). The presence of elevated levels of the 
proto-oncogenes c-fos, c-myc and c-Ki-ras, which occur 
early in the disease, has been established in the murine 
model [9-11]. Whether the formation of cysts resembles a 
hyperplastic state is controversial [12]. No increase could 
be demonstrated in the rate of cell proliferation in ADPKD 
compared with normal tubular epithelial cells in culture 
[13]. 
In order for cyst formation to take place the tubule 
distends up to 1000-fold and this is only possible if the 
tubular basement membrane (TBM) is increasingly compli- 
ant [14,15]. A number of changes have been reported in 
basement membranes of ADPKD kidneys [13], including 
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thickening and lamination [16], an increase in collagen [17] 
and a decrease in the heparan sulphate proteoglycan con- 
tent [14,18]. 
Laminin is a glycoprotein with an approximate molecu- 
lar weight of 900 000 consisting of three polypeptide chains 
constituting a cruciform structure [19]. It forms an inde- 
pendent network in basement membranes [20] and frag- 
mentation of laminin by limited proteolysis has been in- 
strumental in the elucidation of the domain organisation 
and detailed structure of the molecule [21]. There are a 
number of sites within the laminin molecule which are 
susceptible to attack by proteases, e.g., by pepsin [22,23], 
trypsin, chymotrypsin, elastase, subtilisin, S. aureus pro- 
tease [24], cathepsin G [25] and stromelysin [26]. Fragment 
P1 is the most resistant to pepsin and includes the inner 
region of the cross. It is rich in cysteine and glycine and 
has some homology with epidermal growth factor (EGF) 
and transforming rowth factor c~ (TGF-ce [27,28]). The 
P1 fragment, consisting of three short arms of the molecule, 
contains an RGD sequence which is cryptic, and becomes 
exposed after proteolytic digestion. This is known to pos- 
sess cell binding activity [29]. The E8 fragment, generated 
by elastase digestion, has cell binding and polarisation 
activity [30]. Laminin may also possess growth-promoting 
activity (El fragment) which can be compared to the 
epidermal growth-promoting activity of EGF [31]. 
Human laminin, in intact form and as pepsin-cleaved 
fragments P1, P2 and P3, was isolated following limited 
proteolysis from placenta by Dixit [32]. Fragment P2 (Mr 
250000 to 290000 on SDS-PAGE) appeared identical to 
fragment P1 [33]. In the present study we have prepared 
and characterised fragments from human placenta, with 
similar characteristics to fragments found elevated in serum 
of individuals exposed to perchloroethylene [34] and urine 
of diabetic patients [35]. We then investigated whether 
these fragments could affect the growth of normal tubular 
epithelial cells and epithelial cells from ADPKD patients, 
by monitoring the incorporation of [3H]thymidine [31]. 
sodium chloride and after centrifugation the pellet was 
redissolved in 0.02 M Tris-HC1 buffer (pH 7.4), containing 
1.0 M sodium chloride. The solution was dialysed exhaus- 
tively against he same buffer but containing 2 M urea and 
0.02 M sodium chloride. The negatively charged laminin 
fragments were separated from other major extracellular 
matrix molecules using DEAE-Sephacel gel chromatog- 
raphy (Pharmacia, Uppsala, Sweden) either in a column 
[36] or batchwise. The laminin-rich material was further 
purified by digestion with Cl. histoliticum collagenase 
(Worthington Biochemical Corp, NJ, USA) at an 
enzyme:substrate ratio of l:100 at 37°C for 2 h [36]. The 
resulting material was lyophilised and a 25-mg portion of 
the freeze-dried product (yield: 1.35 g/kg of placental wet 
weight) was resuspended in 3 ml 0.02 M Tris-HC1 buffer 
(pH 7.4) containing 1M calcium chloride. The sample was 
loaded onto a 2.6 cm X 90 cm Bio-Gel A-1.5m agarose 
column (Bio-Rad Laboratories, Richmond, CA, USA) at a 
flow-rate of 25 ml /h  and the absorbance of the fractions 
was monitored at 280 and 230 nm. The laminin fragments, 
designated N1 to N7, were separated and compared to 
molecular weight standards (Pharmacia-LKB, Sweden). 
2.3. Isolation of the P1 fragment from the NI fraction 
The first fraction eluted from the Bio-Gel A-1.5m col- 
umn (designated N1) was concentrated on an Amicon 
stirred cell (Mr cut-off 50000) and then loaded onto a 
2.5 X 85 cm S-500 gel filtration column (Pharmacia) at a 
flow rate of 25 ml /h  and 5-ml fractions were collected. 
The purity of the fractions was assessed by SDS-PAGE. 
The P1 fragment [31], designated P2 by Dixit [32], identi- 
fied by absorption at 230 nm, was used in cell proliferation 
studies. 
2.4. Purification of polyclonal anti-human placenta N5 
antibodies 
2. Materials and methods 
2.1. Engelbreth Holm swarm (EHS) tumour 
Laminin was extracted from EHS tumour [36] and 
purified by the procedure of Schittney and Yurchenko [37]. 
The purity of the laminin was confirmed on 4-7% SDS- 
PAGE. 
2.2. Preparation of laminin fragments 
Laminin fragments were prepared by the method of 
Dixit [32]. Briefly, the homogenised human placenta was 
digested with pepsin (Sigma Chemicals) for 40 h at 4°C. 
The solubilised material was then precipitated with 1.9 M 
Rabbit antibodies against a single gel band component 
of N5 were prepared as described elsewhere [35]. They 
were found to cross-react with N3 and N4 fragments but 
had no cross-reactivity at working dilutions with whole 
laminin, type IV collagen, NC-1 fragments of type IV 
collagen, human serum albumin or IgG [35]. The freeze- 
dried laminin fragments (10 mg) were coupled to 0.7 g 
(2.5 ml) of CNBr-activated Sepharose 4B gel (Pharmacia 
LKB, Sweden) at room temperature according to the man- 
ufacturer's protocol. The chromatographic procedures were 
then performed according to the method of Avrieux and 
Williams [38]. An aliquot of 3.1 ml of antiserum was 
diluted 4-fold with 0.025 M Tris-HC1 buffer (pH 7.4, 0.15 
M sodium chloride) and loaded onto the affinity column 
pre-washed with Tris-saline buffer (flow-rate: 6 ml/h). 
The column was eluted with 0.1 M glycine (pH 2.2), and 
the pH of the fractions et to 8.5 by the addition of solid 
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Tris. The fractions elected on the basis of absorption at 
280 nm were pooled and the purified antibody was used to 
probe Western blots. 
2.5. SDS-PAGE and Western blotting 
The purity of the lamimn fragments was assessed using 
5-20% SDS-PAGE gradient gels and Western blotting in a 
Bio-Rad Mini Protean II system. Rainbow markers (14 300 
to 200 000; Amersham International, Amersham, UK) were 
applied to the gel and protein bands were visualised with 
Coomassie Brilliant Blue R (Sigma Chemicals, Poole, 
UK). Following transfer of protein bands to nitrocellulose 
they were reacted with affinity-purified polyclonal anti-hu- 
man placental laminin N5 fragment rabbit IgG (dilution 
1:500). Bound IgG was reacted with goat horseradish 
peroxidase (HRP) conjugated anti-whole rabbit IgG anti- 
body (DAKO A/S,  Glostrup, Denmark; 1:1000) and colour 
developed using 3,3'-diaminobenzidine tetrahydrochloride 
(10 mg/200 ml of 0.1 M Tris-HC1 buffer, pH 7.6). 30% 
hydrogen peroxide (50/zl, Sigma, Poole Dorset, UK) was 
added per 100 ml of 3,3'-diaminobenzidine tetrahydrochlo- 
ride immediately prior to use. 
2.6. Epithelial cell culture 
Polycystic kidneys were obtained from patients with 
ADPKD and transported a~t 4°C. Dissection was carried out 
within 24 h of nephrectomy. Epithelial cells were isolated 
by a modification of the method of Carone et al. [13]. The 
outer cyst surface was removed with a scalpel and trans- 
ferred to ice-cold Dulbecco's Modified Eagle's Medium: 
Ham's Formula 12 (DME:F12; 1:1, containing penicillin 
(100 U/ml)  and streptomycin (100 U/ml), Gibco BRL). 
The cell sheet was minced into 1-mm z pieces, which were 
digested for up to 45 min with collagenase (0.2%, Wor- 
thington), hyaluronidase (0.25%, Sigma) and DNase 
(0.08%, Sigma) in DME:F12, before centrifugation at400 
× g for 5 min. The pellet was washed twice in PBS, and 
resuspended in DMEM:F12 to which had been added 
Nu-Serum (10% v/v,  Collaborative Research, Bedford, 
MA, USA). The cells were seeded onto 25-cm 2 flasks 
precoated with Vitrogen 100 (1 mg/ml in sterile acetic 
acid, 0.1% v/v,  Celtrix Pharmaceuticals, Santa Clara, CA, 
USA). Normal renal epithelial cells were isolated from 
sections of kidney obtained following surgical removal for 
neoplasm. Minced normal renal cortex was digested for 
60-90 min with proteolytic enzymes and the released cells 
were filtered through a 3qT-/zm nylon mesh and washed 3 
times with PBS. The cells were suspended in DMEM:F12 
plus 10% NuSerum and seeded onto Vitrogen-coated flasks. 
Both normal and ADPKD monolayers were then treated 
identically. Cell monolayers were maintained in the above 
medium and in a humidified atmosphere of 5% v /v  
CO2:95% air at 37°C. Cells could be passaged 1:3 for at 
least 4-6 passages following trypsinisation. Cells were 
cultured and sub-cultured, when necessary, in the same 
medium containing cis-4-hydroxy-L-proline (75 /zg/ml) 
[39]. 
2.7. Cell proliferation studies 
Normal and polycystic cells at p4 were seeded in 
24-well culture plates precoated with Vitrogen 100 at a 
density of 105 cells/well. Triplicate cell monolayers were 
supplemented with 1.0 ml labelling medium (DME:F12 
plus 10% Nu serum containing 2 /~Ci/ml [3H]thymidine 
(Amersham) and external agents. The external agents used 
were EHS laminin, and placental laminin fragments P1, 
N3, N4 and N5, each at a concentration of 100 p.g/ml 
medium. Controls (labelled medium only) and tests were 
performed for each cell type. Cells were harvested by 
trypsinisation at 24, 48, 72 and 96 h. Each well was 
washed twice with 0.5 ml PBS and washings added to the 
cell suspension to give a final volume of 1.5 ml. Scintilla- 
tion fluid (13.5 ml; Optiphase Hi-safe II, Wallac) was 
added to the cell suspension which was then sonicated 
(Soniprep, Amp 12, 2 × 30 s). The radioactivity present 
was counted on a Rackbeta 1209 Liquid Scintillation 
Counter (Pharmacia). 
2.8. Cyst fluid 
Cyst fluid was taken from polycystic kidneys and stored 
at -20°C until required. 
3. Results 
3.1. Purification of laminin fragments 
When laminin fragments from placenta were applied to 
Bio-Gel A-1.5 m, six components designated N1 and N3 
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Fig. 1. Separation of laminin fragments on a Bio-Gel A-1.5m column. 
Fractions (5 ml) were collected and fractions numbers 30-32 (N1), 
37-40 (N3), 43-46 (N4), 49-53 (N5) and 56-61 (N6) were pooled 
separately, dialysed against distilled water and freeze-dried. Yields: NI: 
2.7 rag; N3:2.0 mg; N4:2.5 rag; N5:3.2 mg and N6:2.0 mg. I1, 
absorbance at230 nm; [:], absorbance at280 nm. 
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Fig. 2. Determination of Mr values for laminin fragments N1 to N7. The 
log (Mr) = f (Kav) linear was obtained using the following standards: 1, 
ferritin (Mr, 440000); 2. catalase (Mr, 232000); 3, aldolase (Mr, 158 000); 
4. bovine serum albumin (Mr, 67000); 5, ovalbumin (Mr, 43000); 6, 
chymotrypsinogen A (Mr, 25000) and 7, myoglobin (Mr, 16900). The 
void volume (V o) and the total volume (V t) were determined with Blue 
Dextran 2000 (Mr, 2000000) and riboflavin (Mr, 376.4) respectively. 
Table 1 
Mf values of laminin fragments determined using SDS Page and Western 
blotting under non-reducing conditions 
Fragment Coomassie blue Immunostaining 
N3 166000 diffuse bands between 
18800 and 105000 
116000 114000 
N4 n.d. 116 000 
84000 * 81 000 * 
n.d. 56000 * 
N5 n.d. 110000 
n.d. 81000 
72 000 68 000 
54 000 * 56 000 * 
n.d. 53000 
Denotes major protein bands. 
n.d., not detectable. 
to N7 were separated (Fig. 1). Their Mr values were 
900000 (N1), 390 000 (N3), 240 000 (N4), 116 000 (N5), 
66000 (N6) and 28 000 (N7) (Fig. 2). When the same 
material was run on a Bio-Rad A-5m Gel column, a very 
similar elution pattern was observed but there was an 
additional minor peak N2 between N1 and N3. However, 
separations were routinely carded out on Bio-Gel A-1.5m. 
The N2 peak absorbed poorly at 230 nm, indicating the 
absence of laminin; this peak was therefore not investi- 
gated further. The mobility of the various fragments on 
SDS-PAGE is shown in Fig. 3. N4 and N5 each contained 
a major strongly staining component, while N3 stained 
more faintly and Mr values were approximately a third 
(N3 and N4) or a half (N5) of those determined by gel 
filtration (Table 1). When the blot was probed using the 
affinity purified polyclonal antibody raised against N5, N4 
or N3, it reacted with these components as expected but 
also with a number of other components present in the 
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Fig. 4. SDS-Page (A) and Western blotting (B) of laminin fragments from 
cyst fluid. Laminin fragments were affinity-purified from cyst fluid and 
run on the gel under non-reducing conditions. Lane 1 contains laminin 
fragments - 3.9 /.tg of protein was applied; Lane 2 contains Rainbow 
Markers (Amersham). 
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Fig. 3. SDS-Page (A) and western-blotting (B) of laminin fragments N3 (lane 3), N4 (Lane 4) and N5 (Lane 5) under non-reducing conditions. Lane 2 
shows the protein pattern for the laminin fragments before separating them on a Bio-Rad A1.5m Gel column (Fig. 1). 4.5 /xg of protein was applied to 
each track. Lanes 1 and 6 contain Rainbow Markers (Amersham). 
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Fig. 5. Elution profile of the N1 peak from a S-500 gel filtration column. 
The N1 peak fraction from three A1.5m column runs were pooled and 
freeze-dried, giving a final yield of 8.0 mg which was applied to the 
S-500 gel. Fractions 40-51 and 61-75 were collected and pooled. After 
dialysis and freeze-drying the yield from Peak A was 2.35 mg and peak B 
3.5 mg. Absorbance at 280 nm ra, absorbance at230 nm II. 
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fractions from gel filtration (Fig. 3). Similar fragments 
were observed in ADPKD fluid (Fig. 4). The various 
molecular weights of the components are given in Table 1. 
N1 contained P1 and P2 (Fig. 5) as originally described by 
Dixit [32], P1 probably being intact laminin or laminin 
with a small number of removed residues, while P2 is 
equivalent to P1 [33]. 
LABELLING TIME (h) 
Fig, 7. Effect of laminin fragments on A. ADPKD and B. normal renal 
cells at 105 cells/well. 13, control; O, placental P1 (Dixit P2); • N5; 
and, • EHS laminin. All additives were present in the medium at a 
concentration f 100 /xg/ml. Similar profiles to that obtained following 
the addition of the laminin N5 fragment were also found when N3 and 
N4 were added to the culture medium. This data has been omitted for 
clarity. 
3.2. Cell proliferation studies using laminin fragments 
ADPKD and normal cells seeded and labelled as de- 
scribed in Section 2 were harvested after 24, 48, 72 and 96 
h and the incorporated tritium label counted (Fig. 6). The 
data shown indicate that dae proliferative ffect seen with 
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Fig. 6. Growth curves of ADPKD and normal cells in culture. Q, 
ADPKD cells; I:3, normal cells. Results are given as the mean-t-S.E.M. 
of triplicate determinations. 
the ADPKD cells is not due to the culture conditions used. 
The ADPKD cells grew slightly more rapidly than normal 
tubular epithelial cells over the time course of the experi- 
ment. The rate of incorporation of [3H]thymidine into 
ADPKD cells was increased in the presence of the laminin 
fragments P1 [33], N3, N4 and N5 (Fig. 7). This occurred 
in the presence of intact laminin, but to a lesser extent. The 
most pronounced effect occurred between 48 and 96 h 
after labelling of the fragments. Normal renal epithelial 
cells also exhibited an increased rate of [3H]thymidine 
incorporation in the presence of laminin fragments, al- 
though the effect was less than that observed with the 
ADPKD cells. 
4. Discussion 
Laminin is the major glycoprotein found in basement 
membranes [40]. Breakdown products of laminin are found 
in serum and are indicative of the normal turnover of 
basement membranes. An increase in basement membrane 
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breakdown/turnover occurs in a number of diseases and 
the laminin P1 fragment [33] is the most widely used 
marker for monitoring patients with malignancies and liver 
disease [41]. However, laminin fragment P1 is only present 
in urine in very low amounts. The smaller fragments 
between 50 and 150 kDa are also present in urine, and are 
increased in diabetic subjects with renal disease [35]. An 
ELISA procedure incorporating an antibody raised against 
placental aminin fragments isolated following protease 
digestion [32] was used to demonstrate an increase in 
serum laminin fragments in individuals exposed to the 
solvent perchloroethylene [34,42]. The increase in low 
molecular weight laminin fragments in serum and urine is 
therefore indicative of changes in the extracellular matrix 
due to the effect of disease or toxic damage. Low molecu- 
lar weight laminin fragments are present in cyst fluid 
obtained from patients with autosomal dominant polycystic 
kidney disease (Fig. 4). 
The data presented in this study confirm the complexity 
of the components released from laminin by protease 
digestion. The differences between the Mr values obtained 
with gel filtration and SDS-PAGE found in this study may 
indicate an aggregation of the pepsin-cleaved laminin frag- 
ments or, more likely, can be explained by the highly 
elongated, rigid rod-like shape of the fragments. It is worth 
noting that the Mr for laminin fragments determined by gel 
filtration have, to our knowledge, not been published thus 
far. Proteolytic digestion in vivo of laminin present in the 
extracellular matrix may result from multiple protease 
activity and it is of particular interest hat cyst fluid in 
ADPKD is known to contain stromelysin I [43]. The 
breakdown products following stromelysin I cleavage of 
laminin are similar to pepsin-derived fragments of laminin 
[26] and to those found in body fluids [35]. If laminin 
fragments are able to accumulate in cyst fluid they could 
affect the growth characteristics of the tubular epithelial 
cells lining the cyst. In our laboratory, purified anti-human 
laminin N5 fragment antibodies have been used in an 
antigen inhibition ELISA, to estimate the quantity of N5- 
like laminin fragments present in cyst fluid. This has been 
found to be high (100 /xg/ml; [17]). The investigation of 
the possible proliferative ffect of N5-1ike fragments iso- 
lated from cyst fluid are now in progress. 
In the studies presented, cell proliferation was observed 
following the addition of laminin fragments to renal tubu- 
lar epithelial cells. The laminin fragments had a greater 
effect on both normal and ADPKD cells when compared 
to intact laminin. The pepsin-resistant fragment P1 could 
function to promote cell growth through interacting with 
receptors and/or through different signal transduction 
pathways. The fragments generated by more stringent 
pepsin digestion of the placenta used in the present study 
are likely to be breakdown products of P1. The stimulatory 
effect of laminin fragments may therefore result from 
several different mechanisms. For example, Panayatou [31] 
has reported that EGF receptors may be involved in 
laminin-induced mitogenesis, because laminin stimulated 
cell growth in Swiss 3T3 cells, but did not stimulate 
growth when these cells were deficient in the EGF recep- 
tor. However, Panayatou [31] failed to demonstrate compe- 
tition of laminin and its active fragments with EGF for the 
same receptor site. Other studies [44] showed that when 
the effect of laminin on 3T3 cells devoid of the receptor 
was compared to that on isogenic 3T3 cells which had 
been transfected with EGF receptor cDNA, the results 
suggested that the EGF receptor may not be involved in 
laminin-induced mitogenesis n 3T3 cells. Panayatou [31] 
suggests that the mitogenic response to laminin is medi- 
ated by a receptor that is associated with the EGF receptor 
and that laminin could bind or cross-link via a different 
receptor than EGF. 
The laminin A chain contains a total of 20 EGF repeats 
[45], the B 1 chain a total of 13 EGF repeats [46] and the 
B2 chain contains 12 EGF repeats [47]. Of these, 26 are 
within the P1 fragment. It is of interest hat the EGF 
receptor has been shown to be partially mislocated to the 
apical surface of the ADPKD epithelial cell [ 12]. However, 
the exact sequence by which EGF binds to its receptor has 
yet to be elucidated, so whether these laminin fragments 
can bind to the EGF receptor has not been determined. 
It should be emphasised that other proliferative compo- 
nents in addition to laminin fragments may also be present 
in the cyst fluid. Examples are EGF and type IV collagen 
breakdown products, which may be other contributary 
factors in the increased proliferative index of ADPKD 
cells in vivo. A number of different laminin binding 
molecules have been identified, including integrins, and 
the possibility that these are differentially expressed on the 
surface of the ADPKD cells may be important. 
The formation of cysts in ADPKD results in a unique 
fluid which bathes the epithelial cells. Since laminin frag- 
ments similar to those isolated from placenta have been 
found in body fluids, it is possible that fragments of 
laminin produced by endogenous proteolytic digestion con- 
tribute to the proliferation of epithelial cells, which is a 
key step in the cystic process. 
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